Efficient silencing of gene expression with modular trimeric Pol II expression cassettes comprising microRNA shuttles

Nucleic Acids Research

Volumn 37, Issue 13, 2009, Pages

  Ely, Abdullah ^a   Naidoo, Tanusha ^a   Arbuthnot, Patrick ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; RNA POLYMERASE II; TRIMERIC ANTI HEPATITIS B VIRUS RNA POLYMERASE II; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE ACTIVITY; GENE CASSETTE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE MUTATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RNA INTERFERENCE; RNA PROCESSING; RNA SEQUENCE; VIRUS INHIBITION; VIRUS REPLICATION; BIOSYNTHESIS; CELL LINE; CHEMISTRY; GENE VECTOR; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

HEPATITIS B VIRUS;

BASE SEQUENCE; CELL LINE; GENETIC VECTORS; HEPATITIS B VIRUS; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; RNA INTERFERENCE; RNA POLYMERASE II; RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANSFECTION; VIRUS REPLICATION;

EID: 67949104971     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp446     Document Type: Article

References (29)

1. Dykxhoorn,D.M., Palliser,D. and Lieberman,J. (2006) The silent treatment: SiRNAs as small molecule drugs. Gene Ther., 13, 541-552.
2. Ambros,V. (2004) The functions of animal microRNAs. Nature, 431 350-355.
3. Ely,A., Naidoo,T., Mufamadi,S., Crowther,C. and Arbuthnot,P. (2008) Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo. Mol. Ther., 16, 1105-1112.
4. Liu,Y.P., Haasnoot,J., ter Brake,O., Berkhout,B. and Konstantinova,P. (2008) Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res., 36, 2811-2824.
5. Boudreau,R.L., Martins,I. and Davidson,B.L. (2009) Artificial microRNAs as siRNA shuttles: Improved safety as compared to shRNAs in vitro and in vivo. Mol. Ther., 17, 169-175.
6. Chung,K.H., Hart,C.C., Al-Bassam,S., Avery,A., Taylor,J., Patel,P.D., Vojtek,A.B. and Turner,D.L. (2006) Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res., 34, e53.
7. Aagaard,L.A., Zhang,J., von Eije,K.J., Li,H., Saetrom,P., Amarzguioui,M. and Rossi,J.J. (2008) Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs. Gene Ther., 15, 1536-1549.
8. Grimm,D., Streetz,K.L., Jopling,C.L., Storm,T.A., Pandey,K., Davis,C.R., Marion,P., Salazar,F. and Kay,M.A. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 441, 537-541.
9. Zeng,Y., Cai,X. and Cullen,B.R. (2005) Use of RNA polymerase II to transcribe artificial microRNAs. Methods Enzymol., 392, 371-380.
10. Zeng,Y. and Cullen,B.R. (2004) Structural requirements for pre-microRNA binding and nuclear export by Exportin 5. Nucleic Acids Res., 32, 4776-4785.
11. Zeng,Y., Wagner,E.J. and Cullen,B.R. (2002) Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell, 9, 1327-1333.
12. Crowther,C., Ely,A., Hornby,J., Mufamadi,M.S., Salazar,F., Marion,P. and Arbuthnot,P. (2008) Efficient inhibition of hepatitis B virus replication in vivo using peg-modified adenovirus vectors. Hum. Gene Ther, 19, 1325-1331.
13. Weinberg,M.S., Ely,A., Barichievy,S., Crowther,C., Mufamadi,S., Carmona,S. and Arbuthnot,P. (2007) Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA. Mol. Ther., 15, 534-541.
14. Nassal,M. (1992) The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J. Virol. 66, 4107-4116.
15. Ebert,M.S., Neilson,J.R. and Sharp,P.A. (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721-726.
16. Good,P.D., Krikos,A.J., Li,S.X., Bertrand,E., Lee,N.S., Giver,L., Ellington,A., Zaia,J.A., Rossi,J.J. and Engelke,D.R. (1997) Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther., 4 45-54.
17. Paul,C.P., Good,P.D., Winer,I. and Engelke,D.R. (2002) Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20, 505-508.
18. Paul,C.P., Good,P.D., Li,S.X., Kleihauer,A., Rossi,J.J. and Engelke,D.R. (2003) Localized expression of small RNA inhibitors in human cells. Mol. Ther., 7, 237-247.
19. Carmona,S., Ely,A., Crowther,C., Moolla,N., Salazar,F.H., Marion,P.L., Ferry,N., Weinberg,M.S. and Arbuthnot,P. (2006) Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol. Ther. 13, 411-421.
20. Zuker,M. (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res., 31, 3406-3415.
21. Weinberg,M.S., Ely,A., Passman,M., Mufamadi,S.M. and Arbuthnot,P. (2007) Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors. Oligonucleotides, 17, 104-112.
22. Yang,P.L., Althage,A., Chung,J. and Chisari,F.V. (2002) Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection. Proc. Natl Acad. Sci. USA, 99, 13825-13830.
23. Lagos-Quintana,M., Rauhut,R., Lendeckel,W. and Tuschl,T. (2001) Identification of novel genes coding for small expressed RNAs. Science, 294, 853-858.
24. Marques,J.T., Devosse,T., Wang,D., Zamanian-Daryoush,M., Serbinowski,P., Hartmann,R., Fujita,T., Behlke,M.A. and Williams,B.R. (2006) A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol., 24 559-565.
25. Song,E., Lee,S.K., Dykxhoorn,D.M., Novina,C., Zhang,D., Crawford,K., Cerny,J., Sharp,P.A., Lieberman,J., Manjunath,N. et al. (2003) Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J. Virol., 77, 7174-7181.
26. Leonard,J.N. and Schaffer,D.V. (2005) Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J. Virol., 79, 1645-1654.
27. Tiollais,P., Pourcel,C. and Dejean,A. (1985) The hepatitis B virus. Nature, 317, 489-495.
28. Arbuthnot,P., Capovilla,A. and Kew,M. (2000) Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J. Gastroenterol. Hepatol., 15, 357-368.
29. Henkler,F.F. and Koshy,R. (1996) Hepatitis B virus transcriptional activators: Mechanisms and possible role in oncogenesis. J. Viral. Hepat., 3, 109-121.